RichardWMcCallumMD

Gastroenterology • El Paso, TX

Physician

Join to view full profile

Are you Dr. McCallum?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 59 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
4801 Alberta Ave
El Paso, TX 79905
Phone+1 915-545-6618

Fax+1 915-215-5386

Summary

Dr. Richard McCallum, MD is a gastroenterologist in El Paso, Texas. He is currently licensed to practice medicine in Texas, Florida, and Kansas. He is affiliated with University Medical Center of El Paso.

Education & Training

UCLA-VA Greater Los AngelesResidency, Internal Medicine, 1972 - 1974
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1970 - 1972
The University of Queensland Medical SchoolClass of 1968

Certifications & Licensure

KS State Medical License 1996 - 2025
TX State Medical License 2014 - 2025
FL State Medical License 2014 - 2016
VA State Medical License 1985 - 2000
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Gastroenterology

Clinical Trials

Inhibition of Gastric Acid is the Key to Satisfactory Relief of Symptoms With Esomeprazole in NUD Patients Start of enrollment: 2003 Oct 01
Completed
Phase 2
Gastroparesis Registry Start of enrollment: 2006 Dec 01
Completed
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females Start of enrollment: 2007 Oct 01
Unknown status
Phase 2, Phase 3
Multi-Channel Gastric Electrical Stimulation for the Treatment of Gastroparesis Start of enrollment: 2006 Feb 01
Completed
Not Applicable
Nortriptyline for Idiopathic Gastroparesis Start of enrollment: 2009 Jan 01
Completed
Phase 3
Continuous Glucose Monitoring and Insulin Pump Therapy in Diabetic Gastroparesis Start of enrollment: 2011 May 01
Completed
Not Applicable
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial Start of enrollment: 2013 Apr 01
Completed
Phase 2
Transcutaneous Electroacupuncture for Gastroparesis Start of enrollment: 2010 Mar 01
Completed
Phase 1
Gastroparesis Registry 2 Start of enrollment: 2012 Jul 01
Completed
Intraluminal Endosonography for Examination of the Structural Changes of the Stomach in Gastroparetic Patients Start of enrollment: 2013 Mar 01
Completed
Not Applicable
Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease Start of enrollment: 2013 Sep 01
Completed
Phase 3
Clinical Management With SPM System and Validation of the SPM 5 Hour Cutoff in Patients With Symptoms of Gastroparesis Start of enrollment: 2014 Jan 01
Terminated
Not Applicable
Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic Gastroparesis Start of enrollment: 2014 Mar 27
Completed
Phase 3
Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men With Diabetic Gastroparesis Start of enrollment: 2014 Apr 01
Completed
Phase 3
Gastric Electrical Stimulation (GES) and Pyloroplasty for the Treatment of Gastroparesis Start of enrollment: 2017 Jan 10
Recruiting
Not Applicable
Join now to see all

Publications & Presentations

PubMed

2 citations
Efficacy and Safety of Robotic Dor Fundoplication on Severe Gastroesophageal Reflux Disease in Patients With Scleroderma
Priyadarshini Loganathan, Mahesh Gajendran, Brian R. Davis, Richard W. McCallum
Journal of Investigative Medicine High Impact Case Reports. 2021-01-01
75 citations
Phase 2b, randomized, double-blind 12-week studies of TZP-102, a ghrelin receptor agonist for diabetic gastroparesis
Richard W. McCallum, Anthony Lembo, Tuba Esfandyari, B R Bhandari, Niels Ejskjaer
Neurogastroenterology and Motility. 2013-11-01
9 citations
A randomized, double-blind, placebo-controlled, phase 2b study of the efficacy and safety of velusetrag in subjects with diabetic or idiopathic gastroparesis.
Thomas L Abell, Braden Kuo, Tuba Esfandyari, Nathan D Pfeifer, Maria Grimaldi
Neurogastroenterology and Motility. 2023-04-01

Authored Content

Effectiveness of Bulking Agent (Solesta) Therapy in Fecal Incontinence in Patients Refractory to Conventional Therapies☆☆☆September 2017

Press Mentions

Texas Tech Researchers Investigate Effectiveness of ‘GPS for the Digestive Highway’September 12th, 2024
A GPS for the Gastrointestinal SystemSeptember 11th, 2024
Real-World Data Analysis Reveals a Lower Risk of Tardive Dyskinesia (TD) with Metoclopramide Than Previously ReportedMay 23rd, 2022
Join now to see all

Grant Support

New Diagnosis And Treatment Approaches For Patients Wit*National Institute Of Diabetes And Digestive And Kidney Diseases2008–2010
New Diagnosis And Treatment Approaches For Patients Wit*National Institute Of Diabetes And Digestive And Kidney Diseases2008
11th Biennual Meeting Of The American Motility SocietyNational Institute Of Diabetes And Digestive And Kidney Diseases2000
Electrical Stimulation To AID Gastric Motility In Gastroparesis PatientsNational Center For Research Resources1996–1997
Effect Of Vasopressin On Gastric Myoelectric ActivityNational Center For Research Resources1996–1997
Can Light Vection Effect Electrogastrogram &Induce Nausea In HumansNational Center For Research Resources1996–1997